CSIMarket
 


Constellation Pharmaceuticals Inc  (CNST)
Other Ticker:  
 

Constellation Pharmaceuticals Inc's Quick Ratio

CNST's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Constellation Pharmaceuticals Inc's Cash & cash equivalent, this led to improvement in Constellation Pharmaceuticals Inc's Quick Ratio to 17.39, above Constellation Pharmaceuticals Inc average Quick Ratio.

Within Major Pharmaceutical Preparations industry 89 other companies have achieved higher Quick Ratio than Constellation Pharmaceuticals Inc in first quarter 2021. While Quick Ratio total ranking in the first quarter 2021 has deteriorated compared to the prior quarter from 268 to 319.

Explain Quick Ratio?
How much Cash & cash equivalents CNST´s has?
What are CNST´s Current Liabilities?


CNST Quick Ratio (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Current Liabilities Change 32.88 % 33.23 % 83.65 % 62.38 % 16.87 %
Y / Y Cash & cash equivalent Change 6.47 % 9.77 % 449.43 % 430.59 % 209.91 %
Quick Ratio MRQ 17.39 15.66 17.33 21.38 21.7
CNST's Total Ranking # 319 # 268 # 320 # 133 # 131
Seq. Current Liabilities Change -18.32 % -4.7 % 15.95 % 47.22 % -18.1 %
Seq. Cash & cash equivalent Change -9.34 % -13.88 % -5.99 % 45.05 % -6.53 %



Quick Ratio first quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 90
Healthcare Sector # 159
Overall Market # 319


Quick Ratio Statistics
High Average Low
21.7 13.54 5.79
(Mar 31 2020)   (Sep 30 2019)




Financial Statements
Constellation Pharmaceuticals Inc's Current Liabilities $ 22 Millions Visit CNST's Balance sheet
Constellation Pharmaceuticals Inc's Cash & cash equivalent $ 382 Millions Visit CNST's Balance sheet
Source of CNST's Sales Visit CNST's Sales by Geography


Cumulative Constellation Pharmaceuticals Inc's Quick Ratio

CNST's Quick Ratio for the trailling 12 Months

CNST Quick Ratio

(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Current Liabilities TTM Growth 32.88 % 33.23 % 83.65 % 62.38 % 16.87 %
Y / Y Cash & cash equivalent TTM Growth 6.47 % 9.77 % 449.43 % 430.59 % 209.91 %
Quick Ratio TTM 17.87 18.64 19.62 17.69 13.86
Total Ranking TTM # 139 # 141 # 3686 # 30 # 159
Seq. Current Liabilities TTM Growth -18.32 % -4.7 % 15.95 % 47.22 % -18.1 %
Seq. Cash & cash equivalent TTM Growth -9.34 % -13.88 % -5.99 % 45.05 % -6.53 %


On the trailing twelve months basis Due to decline in Current Liabilities in the I Quarter 2021 to $21.98 millions, cumulative Quick Ratio decreased to 17.87 above the CNST average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 44 other companies have achieved higher Quick Ratio than Constellation Pharmaceuticals Inc. While Quick Ratio overall ranking has improved so far to 139, from total ranking during the twelve months ending forth quarter 2020 at 141.

Explain Quick Ratio?
How much Cash & cash equivalents CNST´s has?
What are CNST´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 45
Healthcare Sector # 74
Within the Market # 139


trailing twelve months Quick Ratio Statistics
High Average Low
17.42 12.56 6.26
(Sep 30 2020)   (Sep 30 2019)




Companies with similar Quick Ratio in the quarter ending Mar 31 2021, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2021 MRQ Cash & cash equivalentMar 31 2021 MRQ Current Liabilities
Geovax Labs Inc   46.14 $ 20.854  Millions$ 0.452  Millions
Terns Pharmaceuticals Inc   46.02 $ 195.581  Millions$ 4.250  Millions
Spruce Biosciences Inc   45.13 $ 148.627  Millions$ 3.293  Millions
Guardion Health Sciences Inc   44.09 $ 43.330  Millions$ 0.983  Millions
Hepion Pharmaceuticals inc   43.46 $ 115.449  Millions$ 2.656  Millions
Nighthawk Biosciences inc   43.35 $ 132.057  Millions$ 3.046  Millions
Generation Bio Co   41.79 $ 451.083  Millions$ 10.794  Millions
Acasti Pharma Inc   40.68 $ 60.731  Millions$ 1.493  Millions
Akouos inc   40.61 $ 286.619  Millions$ 7.057  Millions
Dyne Therapeutics Inc   37.58 $ 483.085  Millions$ 12.854  Millions
Oric Pharmaceuticals Inc   36.24 $ 278.141  Millions$ 7.676  Millions
Theriva Biologics inc   36.23 $ 76.887  Millions$ 2.122  Millions
Enveric Biosciences Inc   36.14 $ 22.657  Millions$ 0.627  Millions
Kronos Bio Inc   35.35 $ 398.924  Millions$ 11.285  Millions
Citius Pharmaceuticals Inc   34.76 $ 103.735  Millions$ 2.985  Millions
Astria Therapeutics inc   33.35 $ 146.920  Millions$ 4.406  Millions
Matinas Biopharma Holdings Inc   33.20 $ 60.666  Millions$ 1.827  Millions
Nextcure Inc   32.76 $ 268.236  Millions$ 8.188  Millions
Sage Therapeutics Inc   32.32 $ 2,004.017  Millions$ 62.011  Millions
Ars Pharmaceuticals Inc   32.27 $ 374.205  Millions$ 11.595  Millions
Barinthus Biotherapeutics Plc  32.26 $ 155.935  Millions$ 4.833  Millions
Nkarta Inc   32.00 $ 299.263  Millions$ 9.353  Millions
Annexon Inc   30.54 $ 326.654  Millions$ 10.695  Millions
Alx Oncology Holdings Inc  30.42 $ 429.855  Millions$ 14.129  Millions
Longboard Pharmaceuticals Inc   29.88 $ 120.851  Millions$ 4.044  Millions
Assembly Biosciences Inc   29.76 $ 214.884  Millions$ 7.221  Millions
Seres Therapeutics Inc   29.54 $ 242.800  Millions$ 8.218  Millions
Arcutis Biotherapeutics Inc   29.05 $ 444.927  Millions$ 15.314  Millions
Keros Therapeutics Inc   28.51 $ 255.203  Millions$ 8.950  Millions
Statera Biopharma Inc fka Cytocom Inc   28.22 $ 14.623  Millions$ 0.518  Millions

Date modified: 2023-03-23T23:41:31+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com